Loop Capital analyst Chris Kapsch attributes the pressure in shares of Albemarle to headlines tied to the company's intended Chilean lithium expansion plans. The analyst, who admits this "could understandably be construed as negative for the stock," does not believe Albemarle's longer-term expansion plans in Chile are in "jeopardy whatsoever." Kapsch recommends buying Albemarle on the weakness and keeps a Buy rating on the name with a $130 price target. According to Bloomberg, La Tercera newspaper reported over the weekend that Chile's commission of nuclear energy revoked an authorization to Albemarle to increase the quota of lithium production that had been approved earlier this year.